Portfolio company
GT Medical Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QV Bioelectronics
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
Applied Biotherapeutics
This company develops platform technologies for delivering low-dose radiation precisely at tumor margins for cancer patients undergoing surgical removal.
Coherence Neuro
This company develops implantable brain-computer interfaces and neurostimulation devices to monitor and treat brain cancer for patients with gliomas.
Coherence
This company develops minimally invasive implants and neurotechnology to monitor and manage cancer via real-time electrical signaling for patients with aggressive tumours.
Alpheus Medical
This company develops a non-invasive sonodynamic therapy platform using low-intensity ultrasound and tumor-localising drugs to treat patients with glioblastoma and other brain cancers.
CollimateHealth
This company develops microbeam radiation technology for oncology clinics to treat cancer tumours through high-dose, narrow beams that activate immune responses.
RefleXion Medical
This company manufactures biology-guided radiotherapy systems for hospitals and cancer centres to treat primary and metastatic tumours.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
